1. 1. Global Tuberculosis Programme. WHO operational handbook on tuberculosis: Module 4: Treatment: Drug-susceptible tuberculosis treatment. Available from: https://www.who.int/publications-detail-redirect/9789240050761.
2. 2. Global Tuberculosis Programme. WHO operational handbook on tuberculosis. Module 4: Treatment - Drug-resistant tuberculosis treatment, 2022 update. Available from: https://www.who.int/publications-detail-redirect/9789240065116.
3. 3. Ministry of Health and Family Welfare Government of India. Report of the first national anti-tuberculosis drug resistance survey: India 2014–16, 2018;1–24. Available from: https://tbcindia.gov.in/showfile.php?lid=3315.
4. 4. American Thoracic Society. Medical section of the American lung association: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986;134(2):355–363. DOI: 10.1164/arrd.1986.134.2.355.
5. 5. Fox W. Whither short-course chemotherapy? Br J Dis Chest 1981;75(4):331–357. DOI: 10.1016/0007-0971(81)90022-x.